Literature DB >> 12465726

Autoantibodies to human tissue transglutaminase: superior predictors of coeliac disease.

P J Blackwell1, P G Hill, G K T Holmes.   

Abstract

BACKGROUND: Using selected sample populations, we compared sensitivity and specificity of autoantibodies to guinea pig and human tissue transglutaminase to assess if the human antigen is superior for predicting coeliac disease.
METHODS: Four commercial enzyme-linked immunoassay kits using human tissue transglutaminase as antigen were used to measure autoantibody levels in serum samples from untreated adult coeliacs (n = 32). They were from a series of 130 cases diagnosed between 1997 and 1999 and chosen to bias the group towards subjects with negative autoantibodies when measured with guinea pig tissue transglutaminase as antigen. Samples from 38 control subjects (biased towards false-positive levels with guinea pig antigen) were used to compare specificity. We also assessed if human antigen kits could differentiate between levels in normal subjects and in selective IgA deficiency.
RESULTS: Sensitivity for coeliac disease in this selected group using the human antigen kits ranged from 88% to 100%. Three kits showed significantly higher specificity (82%-97%, P < 0.05) than the guinea pig antigen kit (71%) for the samples studied. No kit achieved complete separation between normal autoantibody levels and lower levels in selective IgA deficiency.
CONCLUSIONS: All human antigen kits showed significantly higher sensitivity for coeliac disease compared to guinea pig antigen (P < 0.001). Receiver operating characteristic curves confirmed the superior diagnostic accuracy of the human antigen kits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12465726     DOI: 10.1080/003655202761020551

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  7 in total

1.  Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population.

Authors:  Eloy Fernández; Sabino Riestra; Luis Rodrigo; Carlos Blanco; Antonio López-Vázquez; Dolores Fuentes; Maria Moreno; Carlos López-Larrea
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 2.  Celiac disease in the East and the West: Bridging the gaps between the guidelines and their implementation in daily practice is mandatory.

Authors:  Anmol Dhawan; Ashish Agarwal; Chris J Mulder; Govind K Makharia
Journal:  Indian J Gastroenterol       Date:  2019-06

3.  Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998.

Authors:  Marie-Hélène Metzger; Margit Heier; Markku Mäki; Enzo Bravi; Andrea Schneider; Hannelore Löwel; Thomas Illig; Detlef Schuppan; Heinz-Erich Wichmann
Journal:  Eur J Epidemiol       Date:  2006-04-29       Impact factor: 8.082

4.  Inter- and Intra-assay Variation in the Diagnostic Performance of Assays for Anti-tissue Transglutaminase in 2 Populations.

Authors:  Prashant Singh; Alka Singh; Jocelyn A Silvester; Vikas Sachdeva; Xinhua Chen; Hua Xu; Daniel A Leffler; Vineet Ahuja; Donald R Duerksen; Ciaran P Kelly; Govind K Makharia
Journal:  Clin Gastroenterol Hepatol       Date:  2019-09-20       Impact factor: 11.382

5.  Development of an immunocapture method for measuring IgA antibodies to tissue transglutaminase in the sera of patients with coeliac disease.

Authors:  S El Alaoui; C Gresti
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

6.  Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: meta-analysis.

Authors:  Elias Zintzaras; Anastasios E Germenis
Journal:  Clin Vaccine Immunol       Date:  2006-02

7.  Suboptimal performance of IgG anti-tissue transglutaminase in the diagnosis of celiac disease in a tropical country.

Authors:  Amit Kumar Dutta; Ashok Chacko; Balekuduru Avinash
Journal:  Dig Dis Sci       Date:  2009-03-31       Impact factor: 3.199

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.